William Blair Starts Medpace (MEDP) at Outperform
- Wall St. gains across sectors ahead of Trump inauguration
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Herbalife (HLF) Says SEC Requested Documents on Anti-Corruption Compliance in China; Reviewed with DoJ
- Investment Focus: History suggests Trump month will be stocks down, dollar up
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
William Blair initiated coverage on Medpace (NASDAQ: MEDP) with an Outperform rating.
Shares of Medpace closed at $30.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Ladenburg Thalmann Starts TC Pipelines (TCP) at Neutral
- William Blair Starts Sprouts Farmers Market (SFM) at Outperform
- Benchmark Starts Ameron International (AMN) at Buy
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesWilliam Blair
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!